Grants and Contributions:
Title:
Validation of an Optimized GMP Manufacturing Process for a Novel Multimodal Imaging Agent
Agreement Number:
914044
Agreement Value:
$109,725.00
Agreement Date:
Sep 3, 2018 - Feb 28, 2020
Description:
CF800 is a multimodal imaging agent intended for pre-operative computed tomography (CT) and intraoperative near infrared (NIR) fluorescence image-guided surgical applications. To this point, CF800’s ability to be used for image-guided surgical interventions has been demonstrated in numerous pre-clinical animal models. Based on this positive pre-clinical data, renowned surgical oncologists have expressed an interest in utilizing CF800 for image-guided surgery in cancer patients. To confirm a successful scale up and optimize the technology, we must characterize the formulation (in terms of composition, size, stability, and performance) in order to finalize product specifications for our planned Phase 1 clinical trial.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Toronto, Ontario, CA M5G 0B7
Reference Number:
172-2018-2019-Q4-914044
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
801184847
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 90 days.
Amendment Date
Oct 17, 2019
Recipient's Legal Name:
Nanovista Inc
Federal Riding Name:
University--Rosedale
Federal Riding Number:
35110
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: